HomeBOLT • NASDAQ
add
Bolt Biotherapeutics Inc
Previous close
$4.95
Day range
$4.82 - $5.09
Year range
$4.41 - $13.00
Market cap
9.73M USD
Avg Volume
30.49K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 2.17M | 90.10% |
Operating expense | 3.34M | -12.16% |
Net income | -7.14M | 52.93% |
Net profit margin | -329.37 | 75.24% |
Earnings per share | -3.72 | 53.50% |
EBITDA | -7.41M | 53.68% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 31.91M | -40.69% |
Total assets | 65.05M | -40.50% |
Total liabilities | 32.95M | -11.66% |
Total equity | 32.10M | — |
Shares outstanding | 1.92M | — |
Price to book | 0.30 | — |
Return on assets | -27.40% | — |
Return on capital | -32.44% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -7.14M | 52.93% |
Cash from operations | -9.73M | 30.32% |
Cash from investing | 17.88M | 4.35% |
Cash from financing | 0.00 | — |
Net change in cash | 8.15M | 157.00% |
Free cash flow | -6.80M | 23.05% |
About
Founded
2015
Headquarters
Website
Employees
40
